Contrast-enhanced computed tomography plus gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging for gross classification of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Contrast-enhanced computed tomography plus gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging for gross classification of hepatocellular carcinoma

Published:2017-02-24 Issue:18 Volume:8 Page:29741-29750
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Chen Chuang¹²,Zhao Hui³,Fu Xu⁴,Huang LuoShun⁴,Tang Min⁵,Yan XiaoPeng⁴,Sun ShiQuan⁴,Jia WenJun⁴,Mao Liang⁴,Shi Jiong⁶,Chen Jun⁶,He Jian⁵,Zhu Jin⁷⁸,Qiu YuDong¹⁴

Affiliation:

1. Department of Hepatopancreatobiliary Surgery, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing 210008, Jiangsu, China

2. Department of Hepatopancreatobiliary Surgery, Huai'an Hospital Affiliated to Xuzhou Medical University, Second People's Hospital of Huai'an City, Huai'an 223002, Jiangsu, China

3. Department of Hepatopancreatobiliary Surgery, Nanjing Medical University Affiliated Wuxi Second Hospital, Wuxi 214001, Jiangsu, China

4. Department of Hepatopancreatobiliary Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, Jiangsu, China

5. Department of Radiology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, Jiangsu, China

6. Department of Pathology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, Jiangsu, China

7. Key Laboratory of Antibody Technique of Ministry of Health, Nanjing Medical University, Nanjing 210029, Jiangsu, China

8. Huadong medical Institute of Biotechniques, Nanjing 210029, Jiangsu, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Three-dimensional morphology scoring of hepatocellular carcinoma stratifies prognosis and immune infiltration;Computers in Biology and Medicine;2024-04

2. Association between tumor morphology and efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma;Hepatology Research;2024-02-14

3. Response to Comment on “Subclassification of Microscopic Vascular Invasion in Hepatocellular Carcinoma”;Annals of Surgery;2020-10-16

4. New scoring system for resectable hepatocellular carcinoma with a maximum tumor size of ≤5 cm based on preoperative tumor factors;HPB;2019-10